Director Shareholding

GlaxoSmithKline PLC 02 January 2003 Directors' Interests I give below details of changes in the directors' interests in the Ordinary Shares and ADS Shares of GlaxoSmithKline plc. On 31 December 2002, the following Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and American Depository Shares (ADS's) in the Company through the Annual Re-investment of Dividends paid throughout 2002, as listed below: SmithKline Beecham Non-Executive Directors Retainer Fee and Share Allocation Award - Annual Dividend Reinvestment Non-Executive Director No. of Average Price (£) No. of ADS's Average Price ($) Ordinary Shares Sir Christopher Hogg 31.485 11.53 Mr P Allaire 14.437 36.73 Mr D McHenry 14.437 36.73 Sir Ian Prosser 31.485 11.53 Dr Lucy Shapiro 51.167 11.53 14.437 36.73 GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment Non-Executive Director No. of Average Price (£) No. of ADS's Average Price ($) Ordinary Shares Sir Christopher Hogg 37.830 11.53 Sir Roger Hurn 178.893 11.53 Mr P Allaire 17.459 36.73 Dr Michele Barzach 37.830 11.53 Sir Peter Job 111.409 11.53 Mr J McArthur 31.871 36.73 Mr D McHenry 17.459 36.73 Sir Ian Prosser 74.619 11.53 Dr Ronaldo Schmitz 73.239 11.53 Dr Lucy Shapiro 17.459 36.73 The Company was notified of this information on 2nd January 2003. S M Bicknell Company Secretary 2nd January 2003 This information is provided by RNS The company news service from the London Stock Exchange DSBTMRTMMIMBFJ

Companies

GSK (GSK)
UK 100

Latest directors dealings